Veerhealth Care Intrinsic Value
VEERHEALTH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.98 | ₹4.78 - ₹7.18 | -70.0% | EPS: ₹0.20, Sector P/E: 22x |
| Book Value Method | asset | ₹22.00 | ₹19.80 - ₹24.20 | +10.4% | Book Value/Share: ₹11.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹19.00 | ₹17.10 - ₹20.90 | -4.6% | Revenue/Share: ₹9.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹9.12 | ₹8.21 - ₹10.03 | -54.2% | EBITDA: ₹2.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹20.38 | ₹16.30 - ₹24.46 | +2.3% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹5.98 | ₹5.38 - ₹6.58 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹5.98 | ₹5.38 - ₹6.58 | -70.0% | Revenue Growth: 14.6%, Adj P/E: 16.1x |
| Graham Defensive Method | conservative | ₹7.04 | ₹6.34 - ₹7.74 | -64.7% | EPS: ₹0.20, BVPS: ₹11.00 |
Want to compare with current market value? Check VEERHEALTH share price latest .
Valuation Comparison Chart
VEERHEALTH Intrinsic Value Analysis
What is the intrinsic value of VEERHEALTH?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Veerhealth Care (VEERHEALTH) is ₹9.12 (median value). With the current market price of ₹19.92, this represents a -54.2% variance from our estimated fair value.
The valuation range spans from ₹5.98 to ₹22.00, indicating ₹5.98 - ₹22.00.
Is VEERHEALTH undervalued or overvalued?
Based on our multi-method analysis, Veerhealth Care (VEERHEALTH) appears to be trading above calculated value by approximately 54.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.38 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.55 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 4.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Veerhealth Care
Additional stock information and data for VEERHEALTH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |